UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Development of a decision support tool for primary care management of patients with abnormal liver function tests without clinically apparent liver disease: a record-linkage population cohort study and decision analysis (ALFIE)

Health technology assessment (Winchester, England), 2009-04, Vol.13 (25), p.iii-iv

2009

Volltextzugriff (PDF)

P11 Impact of opiate substitution therapy on hepatitis C treatment oucomes for persons who inject drugs at injecting equipment provision sites in the advance HCV trial

Gut, 2020-09, Vol.69 (Suppl 1), p.A12-A13

2020

Volltextzugriff (PDF)

The Consensus Hepatitis C Cascade of Care: Standardized Reporting to Monitor Progress Toward Elimination

Clinical infectious diseases, 2019-11, Vol.69 (12), p.2218-2227

2019

Volltextzugriff (PDF)

HLA-B5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin

Nature genetics, 2009-07, Vol.41 (7), p.816-819

2009

Volltextzugriff (PDF)

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease

Hepatic medicine: evidence and research, 2014, Vol.6 (default), p.1-10

2014

Volltextzugriff (PDF)

Cost effectiveness and quality of life considerations in the treatment of hepatitis C infection

ClinicoEconomics and outcomes research, 2010-01, Vol.2 (default), p.87-96

2010

Volltextzugriff (PDF)

How to Effectively Monitor Aging Patients with Chronic Hepatitis B: A Review

Clinical interventions in aging, 2022-01, Vol.17, p.1811-1820

2022

Volltextzugriff (PDF)

A sustainable development goal framework to guide multisectoral action on NAFLD through a societal approach

Alimentary pharmacology & therapeutics, 2022-01, Vol.55 (2), p.234-243

2022

Volltextzugriff (PDF)

Injecting heroin – how long until hepatitis C infection obtained?

Journal of hepatology, 2017, Vol.66 (1), p.S274-S274

2017

Volltextzugriff (PDF)

Paracetamol pack size restriction: the impact on paracetamol poisoning and the over-the-counter supply of paracetamol, aspirin and ibuprofen

Pharmacoepidemiology and drug safety, 2002-06, Vol.11 (4), p.329-331

2002

Volltextzugriff (PDF)

New cyclic difference sets with Singer parameters

Finite fields and their applications, 2004-07, Vol.10 (3), p.342-389

2004

Volltextzugriff (PDF)

Character Sum Factorizations Yield Sequences With Ideal Two-Level Autocorrelation

IEEE transactions on information theory, 2015-06, Vol.61 (6), p.3276-3304

2015

Volltextzugriff (PDF)

Implementation of a liver health check in people with type 2 diabetes

The lancet. Gastroenterology & hepatology, 2024-01, Vol.9 (1), p.83-91

2024

Volltextzugriff (PDF)

PTU-080 Efficacy and Safety of Obeticholic Acid (OCA) in PBC Patients with Advanced Disease as Evidenced by Abnormal Bilirubin: An Integrated Analysis

Gut, 2016-06, Vol.65 (Suppl 1), p.A93-A94

2016

Volltextzugriff (PDF)

The Barrett's antigen anterior gradient-2 silences the p53 transcriptional response to DNA damage

Molecular & cellular proteomics, 2004-06, Vol.3 (6), p.534

2004

Volltextzugriff (PDF)

PG119 THE COST-UTILITY OF LIVER DISEASE DIAGNOSIS: ASSESSING GP DECISIONS FOR PATIENTS WITH ABNORMAL LIVER FUNCTION TESTS AND NO OBVIOUS LIVER DISEASE

Value in health, 2008, Vol.11 (6), p.A524-A524

2008

Volltextzugriff (PDF)

Health State Utilities Associated With Attributes Of Treatments For Hepatitis C

Value in health, 2014-05, Vol.17 (3), p.A9-A9

2014

Volltextzugriff (PDF)

UT2 - Health State Utilities Associated With Attributes Of Treatments For Hepatitis C

Value in health, 2014-05, Vol.17 (3), p.A9-A9

2014

Volltextzugriff (PDF)

Paracetamol toxicity: epidemiology, prevention and costs to the health‐care system

QJM : An International Journal of Medicine, 2002-09, Vol.95 (9), p.609-619

2002

Volltextzugriff (PDF)

PTH-082 Do Serum Markers Of Cell Injury And Death Have Potential To Become Mechanistic Markers In Non-alcoholic Fatty Liver Disease (nafld)?

Gut, 2014-06, Vol.63 (Suppl 1), p.A245

2014

Volltextzugriff (PDF)

PTH-082 Do Serum Markers Of Cell Injury And Death Have Potential To Become Mechanistic Markers In Non-alcoholic Fatty Liver Disease (nafld)?: Abstract PTH-082 Table 1

Gut, 2014-06, Vol.63 (Suppl 1), p.A245-A246

2014

Volltextzugriff (PDF)

What is the best treatment?

Journal of viral hepatitis, 2004-09, Vol.11 (s1), p.23-27

Dillon, J. F.

2004

Volltextzugriff (PDF)

Search for circular dichroism in high-Tc superconductors

Physical review letters, 1990-06, Vol.64 (24), p.2949-2952

1990

Volltextzugriff (PDF)

The calcium‐binding domain of the stress protein SEP53 is required for survival in response to deoxycholic acid‐mediated injury

The FEBS journal, 2006-05, Vol.273 (9), p.1930-1947

2006

Volltextzugriff (PDF)

A randomized trial comparing transjugular intrahepatic portosystemic stent‐shunt with variceal band ligation in the prevention of rebleeding from esophageal varices

Hepatology (Baltimore, Md.), 1997-11, Vol.26 (5), p.1115-1122

1997

Volltextzugriff (PDF)

1 – 25 von 206

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(180)
Mit Volltextzugriff
(172)

Publikationsform

Sprache

Englisch
(206)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Development of a decision support tool for primary care management of patients with abnormal liver function tests without clinically apparent liver disease: a record-linkage population cohort study and decision analysis (ALFIE)

P11 Impact of opiate substitution therapy on hepatitis C treatment oucomes for persons who inject drugs at injecting equipment provision sites in the advance HCV trial

The Consensus Hepatitis C Cascade of Care: Standardized Reporting to Monitor Progress Toward Elimination

HLA-B5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease

Cost effectiveness and quality of life considerations in the treatment of hepatitis C infection

How to Effectively Monitor Aging Patients with Chronic Hepatitis B: A Review

A sustainable development goal framework to guide multisectoral action on NAFLD through a societal approach

Injecting heroin – how long until hepatitis C infection obtained?

Paracetamol pack size restriction: the impact on paracetamol poisoning and the over-the-counter supply of paracetamol, aspirin and ibuprofen

New cyclic difference sets with Singer parameters

Character Sum Factorizations Yield Sequences With Ideal Two-Level Autocorrelation

Implementation of a liver health check in people with type 2 diabetes

PTU-080 Efficacy and Safety of Obeticholic Acid (OCA) in PBC Patients with Advanced Disease as Evidenced by Abnormal Bilirubin: An Integrated Analysis

The Barrett's antigen anterior gradient-2 silences the p53 transcriptional response to DNA damage

PG119 THE COST-UTILITY OF LIVER DISEASE DIAGNOSIS: ASSESSING GP DECISIONS FOR PATIENTS WITH ABNORMAL LIVER FUNCTION TESTS AND NO OBVIOUS LIVER DISEASE

Health State Utilities Associated With Attributes Of Treatments For Hepatitis C

UT2 - Health State Utilities Associated With Attributes Of Treatments For Hepatitis C

Paracetamol toxicity: epidemiology, prevention and costs to the health‐care system

PTH-082 Do Serum Markers Of Cell Injury And Death Have Potential To Become Mechanistic Markers In Non-alcoholic Fatty Liver Disease (nafld)?

PTH-082 Do Serum Markers Of Cell Injury And Death Have Potential To Become Mechanistic Markers In Non-alcoholic Fatty Liver Disease (nafld)?: Abstract PTH-082 Table 1

What is the best treatment?

Search for circular dichroism in high-Tc superconductors

The calcium‐binding domain of the stress protein SEP53 is required for survival in response to deoxycholic acid‐mediated injury

A randomized trial comparing transjugular intrahepatic portosystemic stent‐shunt with variceal band ligation in the prevention of rebleeding from esophageal varices

Suchergebnisse filtern